Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo

Menopause

Volumn 16, Issue 4, 2009, Pages 680-688

  Flyckt, Rebecca L ^a   Liu, James ^a   Frasure, Heidi ^a   Wekselman, Kathryn ^b   Buch, Akshay ^b   Kingsberg, Sheryl A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Androgen; Bioavailable testosterone; Free testosterone; Menopause; Salivary testosterone

Indexed keywords

ALBUMIN; PLACEBO; TESTOSTERONE;

ADULT; ALBUMIN BOUND TESTOSTERONE BLOOD LEVEL; ARTICLE; BIOAVAILABLE TESTOSTERONE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; EQUILIBRIUM DIALYSIS; FEMALE; FREE TESTOSTERONE BLOOD LEVEL; GOLD STANDARD; HORMONE BINDING; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PHASE 3 CLINICAL TRIAL; SALIVA ANALYSIS; SEXUAL DYSFUNCTION; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE; TOTAL TESTOSTERONE BLOOD LEVEL;

ADMINISTRATION, CUTANEOUS; DOUBLE-BLIND METHOD; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; PLACEBOS; POSTMENOPAUSE; SALIVA; SERUM ALBUMIN; SEX HORMONE-BINDING GLOBULIN; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 68449085114     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318199d5c4     Document Type: Article

References (26)

1. Padero MC, Bhasin S, Friedman TC. Androgen supplementation in older women: too much hype, not enough data. J Am Geriatr Soc 2002;50:1131-1140.
2. Braunstein GD, Sundwall DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized placebo-controlled trial. Arch Intern Med 2005;165:1582-1589.
3. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105:944-952.
4. Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 2006;13:770-779.
5. Sherwin BB. Changes in sexual behavior as a function of plasma sex steroid levels in post-menopausal women. Maturitas 1985;7:225-233.
6. McCoy NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas 1985;7:203-210.
7. Miller KK, Rosner W, Lee H, et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 2004;89:525-533.
8. Taieb J, Mathian B, Millot F, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 2003;49:1381-1395.
9. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-3853.
10. Guay AT. Screening for androgen deficiency in women: methodological and interpretive issues. Fertil Steril 2002;77:S83-S88.
11. Basaria S, Dobs AS. Clinical review: controversies regarding transdermal androgen therapy in postmenopausal women. J Clin Endocrinol Metab 2006;91:4743-4752.
12. de Ronde W, van der Schouw YT, Pols HA, et al. Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. Clin Chem 2006;52:1777-1784.
13. Ferguson DB. Current diagnostic uses of saliva. J Dent Res 1987;66:420.
14. Baxendale PM, Jacobs HS, James VH. Plasma and salivary androstene-dione and dihydrotestosterone in women with hyperandrogenism. Clin Endocrinol (Oxf) 1983;18:447-457.
15. Bland JM, Altman DG. Correlation, regression and repeated data. BMJ 1994;308:896.
16. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: part 2 - correlation between subjects. BMJ 1995;310:633.
17. Johnson SG, Joplin GF, Burrin JM. Direct assay for testosterone in saliva: relationship with a direct serum free testosterone assay. Clin Chim Acta 1987;163:309-318.
18. Morley JE, Perry HM 3rd, Patrick P, Dollbaum CM, Kells JM. Validation of salivary testosterone as a screening test for male hypogonadism. Aging Male 2006;9:165-169.
19. Pardridge WM. Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab 1986;15:259-278.
20. Cadore E, Lhullier F, Brentano M, et al. Correlations between serum and salivary hormonal concentrations in response to resistance exercise. J Sports Sci 2008;26:1067-1072.
21. Shirtcliff EA, Granger DA, Likos A. Gender differences in the validity of testosterone measured in saliva by immunoassay. Horm Behav 2002;42:62-69.
22. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405-413.
23. Stanczyk FZ. Measurement of androgens in women. Semin Reprod Med 2006;24:78-85.
24. Granger DA, Shirtcliff EA, Booth A, Kivlighan KT, Schwartz EB. The trouble with salivary testosterone. Psychoneuroendocrinology 2004;29:1229-1240.
25. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105:944-952.
26. Dabbs JM. Salivary testosterone measurements: collecting, storing and mailing saliva samples. Physiol Behav 1990;49:815-817.